|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/12 | |
| A61K 47/28 | |||
| A61K 47/34 | |||
| A61K 9/107 | |||
| A61K 9/51 | |||
| A61K 31/5377 |
| (11) | Patento numeris | 3511019 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19156064.8 |
| Europos patento paraiškos padavimo data | 2015-03-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-07-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201461953628 P | 2014-03-14 | US |
| (72) |
BAGRODIA, Shubha, US
LAFONTAINE, Jennifer, US
LOVATT, Zach, US
SHIN, Eyoung, US
SONG, Young, Ho, US
TROIANO, Greg, US
WANG, Hong, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME |
| THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME |